Expertise in
5
conditions

Ana B. Custodio

La Paz, MD, ES 
Expertise in
5
conditions
La Paz, MD, ES 

Overview

Ana Custodio practices practicing medicine in La Paz, Spain.

Ms. Custodio is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Stomach Cancer, and Colorectal Cancer.

She is actively involved in clinical research, co-authoring 73 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

La Paz, MD 28046, Spain
Other Locations
Madrid, MD 00398, Spain
El Pardo, MD 28046, Spain
Castellana, MD 28046, Spain
Murcia, MU, Spain
La Paz, CN, Spain
Majadahonda, MD, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Multi-center, Open-label, Active-controlled Phase 3 Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) Versus Octreotide LAR or Lanreotide ATG in Patients With GEP-NET
A Randomized, Multi-center, Open-label, Active-controlled Phase 3 Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) Versus Octreotide LAR or Lanreotide ATG in Patients With GEP-NET
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2026
Intervention Type: Drug
Study Drugs: CAM2029, Octreotide LAR, Lanreotide ATG
Study Phase: Phase 3
A Phase II/III Randomized Double-blind Study of Sandostatin LAR in Combination With Axitinib Versus Sandostatin LAR With Placebo in Patients With Advanced G1-G2 Neuroendocrine Tumours (WHO 2010) of Non-pancreatic Origin
A Phase II/III Randomized Double-blind Study of Sandostatin LAR in Combination With Axitinib Versus Sandostatin LAR With Placebo in Patients With Advanced G1-G2 Neuroendocrine Tumours (WHO 2010) of Non-pancreatic Origin
Enrollment Status: Completed
Publish Date: April 28, 2026
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Phase II Study to Assess the Activity and Safety of TH-302 in Combination With Sunitinib in Treatment-naïve Patients With Well- and Moderately-differentiated Metastatic Pancreatic Neuroendocrine Tumours (pNET)
A Phase II Study to Assess the Activity and Safety of TH-302 in Combination With Sunitinib in Treatment-naïve Patients With Well- and Moderately-differentiated Metastatic Pancreatic Neuroendocrine Tumours (pNET)
Enrollment Status: Completed
Publish Date: July 27, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

73 Total Publications

Review of Haematological Toxicities in Well-Differentiated Neuroendocrine Tumours: A Case Report and Comprehensive Review of the Literature.
Review of Haematological Toxicities in Well-Differentiated Neuroendocrine Tumours: A Case Report and Comprehensive Review of the Literature.
Journal: Journal of clinical medicine
Published: May 11, 2026

Frequently Asked Questions about Ana B. Custodio

Is Ana B. Custodio a top-rated expert for Pancreatic Islet Cell Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Ana B. Custodio is classified as an Distinguished expert for Pancreatic Islet Cell Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ana B. Custodio participate in research or clinical trials?

Yes. Ana B. Custodio has published 73 articles and abstracts on conditions like Pancreatic Islet Cell Tumor. You can view a list of Ana B. Custodio's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Custodio's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile